Christos Kaskavelis - 11 Jun 2021 Form 4/A - Amendment Insider Report for ADVENT TECHNOLOGIES HOLDINGS, INC. (ADN)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4/A - Amendment
Accepted by SEC
14 Apr 2023, 16:47:58 UTC
Original report date
15 Jun 2021
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Christos Kaskavelis

Key filing fact

Christos Kaskavelis filed Form 4/A - Amendment for ADVENT TECHNOLOGIES HOLDINGS, INC. (ADN) on 14 Apr 2023.

Key facts

  • This page summarizes Christos Kaskavelis's Form 4/A - Amendment filing for ADVENT TECHNOLOGIES HOLDINGS, INC. (ADN).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 14 Apr 2023, 16:47.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ADN transaction

Common Stock

Award

Transaction value
$0
Shares
+345,794
Change %
+18%
Price
$0.000000
Shares after
2,247,502
Date
11 Jun 2021
Ownership
Direct
Footnotes
F1
ADN holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,802,405
Date
11 Jun 2021
Ownership
By Nemaland Ltd.
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents 345,794 restricted stock units that is a contingent right to receive common stock upon vesting granted pursuant to the Advent Technologies Holdings, Inc. 2021 Equity Incentive Plan, dated as of February 4, 2021. The restricted stock units will vest 25% upon each anniversary of February 4, 2021, the vesting commencement date, until the fourth anniversary of the vesting commencement date.

Footnote F2

Reflects shares of Issuer's common stock beneficially owned through Nemaland Ltd.

SEC remarks

This Form 4A amends and restates Table I of the Form 4 filed June 15, 2021, which inadvertently incorrectly stated the Reporting Person's aggregate shares of common stock owned directly and indirectly following the grant reported on such Form 4.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .